Related by context. All words. (Click for frequent words.) 55 Pre IND 54 biostatistical analysis 53 ILLUSTRATE 52 ISTH 51 NACFC 51 EULAR Annual 50 rigorously peer reviewed 50 HDL Selective Delipidation 50 fosbretabulin 50 AACR San Antonio 50 Phase III multicenter 49 Late Breaker 49 ICAAC IDSA 49 NCCN Drugs 49 HALTS 49 PROTECT II 49 Recombinant DNA Advisory 48 genomic biomarker 48 League Against Rheumatism 48 Multiple Ascending Dose 48 Pharmacoeconomics 48 USP NF 48 ACNP 48 ACCLAIM II 48 ASGCT 48 Appropriateness Criteria 48 inhaled AAT 48 preclinical pharmacokinetic 48 Pediatric Oncology Branch 48 Accessed #/#/# [001] 48 IntroductionThe 47 Clinical Practice Guideline 47 TORISEL TM 47 R rosiglitazone maleate 47 International Nonproprietary Names 47 Phase 1a clinical 47 RECOMMENDS THAT 47 phase IIIb 47 EUROGIN 47 Panzem ® 47 Surviving Sepsis Campaign 47 tropism testing 47 Completely unsupported 47 CaPSURE 47 EFNS 47 SIMPADICO 47 intratympanic 47 ASBMR 47 preclinical efficacy 47 Harry Palmin President 47 ADEAR Center 47 Prosaptide 47 Unstable Angina 47 DAIDS 47 Human Proteome Organization 47 mediated inhibition 47 Expert Advisory Panel 47 ASNR 46 Dr. McHutchison 46 Files Amicus Brief 46 CA9 SCAN 46 Urocortin 2 46 MYTHOS trial 46 NICE SUGAR 46 analyst Mark Schoenebaum 46 MAQC 46 toxicogenomic 46 Scientific Advisory Panel 46 MEDCAC 46 ANSI accredited 46 ANSI accredited standards 46 PHRM 46 NCVHS 46 UGC AICTE 46 Vertos II 46 Dr. Gulfo 46 ASCO GI 46 Carla Vecchiotti 46 International Nasdaq CRAI 46 Postmarketing 46 visit http:/www.clinicaltrials.gov/ 46 Scientific Counselors 46 HF ACTION 46 Bjelakovic 46 SCENIHR 46 Endocrine Practice 46 aerosolized surfactant 46 BioZ ICG 46 CARE HF 46 Journal Editors ICMJE 46 number NCT# ClinicalTrials.gov 46 Index SPI SPIEX 46 pharmacokinetic pharmacodynamic 46 Urocidin ™ 46 BHIVA 46 ARISE Phase III 46 Begins Dosing 46 ICON7 46 SmPC 46 Pharmacodynamic 46 NCCN guidelines 46 Phase IIb III 46 ISPOR 46 dioxin reassessment 46 Deforolimus 45 Braunwald 45 ISSM 45 commented Alexis Borisy 45 USpella 45 visceral metastases 45 #-# Full Text 45 Consensus Statement 45 IJIS 45 hydroxamic acid 45 Submits Response 45 Carotid Artery Stenting 45 receptor antagonism 45 Steering Committees 45 Berkelhamer 45 SOM# 45 ECTRIMS 45 Öko Institut 45 EAACI 45 Pharmacologic 45 ADA Scientific Sessions 45 EUROCAE ED #B 45 empirically validated 45 Neurocognitive 45 Reproducibility 45 AVERROES 45 ELSO 45 Announce Collaboration Agreement 45 predictive biomarker 45 Society CTOS 45 somatostatin analog 45 human IgG1 monoclonal 45 Primary endpoints 45 Kronmal 45 Presents Preclinical 45 EUROCAE 45 prognostic biomarker 45 America HFSA 45 TRX1 44 Subgroup analyzes 44 Risk Stratification 44 Human Proteome Project 44 Initiate Phase II 44 Eugene Braunwald MD 44 CG# [003] 44 ExTRACT TIMI 44 PROTECTED AREAS 44 SinuNase ™ 44 polycythemia vera essential thrombocythemia 44 Vaxfectin R adjuvant 44 Gastroenterological 44 Symptom severity 44 Venereology 44 Quantitative PCR 44 GENASIS 44 Common Toxicity Criteria 44 Multi Stakeholder 44 ProMIS TM 44 EMBO Meeting 44 dual endothelin receptor antagonist 44 mesilate 44 PROactive study 44 pregabalin Lyrica 44 choroidal neovascularisation 44 Devices Advisory Panel 44 CYP#D# inhibitor 44 Combating Counterfeit Drugs 44 Trovax 44 CALERIE 44 LungCAD 44 LAB CGRP 44 Cosmetic Ingredient Review 44 secretagogues 44 National Guideline Clearinghouse 44 Pre RELAX AHF 44 PHFI 44 Connective Tissue Oncology 44 prospective observational studies 44 budesonide MMX Phase III 44 HIV coinfected 44 PFO migraine 44 IASC Foundation 44 Chronic Renal Failure 44 myeloid metaplasia 44 NIST Smart Grid 44 evaluating satraplatin 44 APTIMA HPV assay 44 ORAL Sync 44 Emezine R 44 QOPI 44 #nd EORTC NCI 44 BEZ# 44 generalisable 44 Appendix VII 44 Orally Active 44 NAEPP 44 Add.1 44 MEND CABG II 44 ACC AHA ESC 44 CombAT study 44 AstraZeneca Boehringer Ingelheim 44 BLA filing 44 sunitinib Sutent 44 novel therapeutic antibodies 44 IASCF 43 AUA Annual Meeting 43 Notified Bodies 43 mild hepatic impairment 43 CERHR 43 Modrenal 43 florbetaben 43 Atypical Antipsychotic 43 Teriflunomide 43 ISO IEC JTC 43 Presents Positive 43 ASHG 43 Cytolin 43 Digestive Diseases Week 43 SCAI Annual 43 Hedgehog antagonist 43 BHGI 43 · Coordinate 43 boards IRBs 43 Mary Tagliaferri 43 #th Interscience Conference 43 KP Narasimhan 43 Spokesperson Abhishek Manu 43 BiTE R 43 Judith Hochman 43 conferences symposia 43 ENTOCORT EC 43 mGluR5 inhibition 43 IVDMIA 43 Breaking Clinical Trials 43 telomerase inhibitor drug 43 #st Annual Meeting 43 methodologically rigorous 43 glucocorticoid induced 43 ICAEL 43 #th Annual Interscience 43 Phase #/#a clinical 43 BrachySil TM 43 comparative genomic hybridization 43 eClinical trials 43 intersessional meetings 43 RCEP 43 Successfully Completes Phase 43 MEND CABG 43 NVLAP 43 NuroPro PD 43 National Coverage Determination 43 Makes Recommendations 43 Ayua 43 oral PTH 43 multicenter Phase III 43 Respiratory Society 43 skin sterol 43 ACTIVE W 43 Di Bisceglie 43 CCST 43 SAIs 43 Coordinate Metrology Society 43 relapsed MCL 43 Erythropoiesis Stimulating Agents ESAs 43 HFSA 43 preclinical pharmacology 43 workplans 43 CPA ABV 43 Hodgkin lymphoma HL 43 oral prednisolone 43 AAN Annual Meeting 43 R lenalidomide 43 BZA CE 43 cystic fibrosis bronchiectasis inhalation 43 Psychopharmacologic Drugs Advisory 43 International Myeloma Workshop 43 HPV induced carcinogenesis 43 Phase III HEAT 43 ACGIH 43 intranasal corticosteroids 43 European CanCer Organisation 43 Vascular Disease Foundation 43 Vapor Intrusion 43 GCP compliant 43 resultsof 42 Larry Cornman physicist 42 lymphomas leukemias 42 ICCAD 42 Thieme publishes 42 ITU algorithms PAMS 42 ICRP 42 Triapine R 42 Yurgelun Todd 42 SIPit interoperability 42 comorbid psychiatric disorders 42 AE# vaccine 42 Paulo Sérgio Pinheiro 42 SABCS 42 Comorbidities 42 USOTC ATSMY announces 42 REPLACE Registry 42 Prostate Cancer Symposium 42 enzyme immunoassay EIA 42 methodologists 42 Hypertension ESH 42 Apoptone 42 APEX AMI 42 Ultrafast Insulin 42 TransVax 42 Plaquenil 42 psoriatic arthritis PsA 42 ABRF 42 Zemplar Capsules 42 perfusion CT 42 ARIKACE ™ 42 revaccinate according 42 FDG PET imaging 42 antimicrobial susceptibility 42 OMAPRO ™ 42 GLP toxicology studies 42 Shows Efficacy 42 inferential statistics 42 Mineral Reserves Best Practices 42 surgical debulking 42 CPT coding 42 ALK inhibitors 42 Poster Discussion 42 Zhejiang Hisun 42 manually curated 42 respectfully submits 42 Psyadon 42 AACR #st Annual Meeting 42 OvaRex MAb 42 serious cardiovascular thrombotic 42 BACcel ™ system 42 Competent Authorities 42 Ambulatory EHR ensures 42 ® pioglitazone HCl 42 Transcatheter Cardiovascular Therapeutics 42 proteomic biomarkers 42 ASCO Breast Cancer 42 Intervention Effectiveness CATIE 42 Diabetic Neuropathy 42 Embolic Protection Device 42 NABTT 42 FGDC 42 Bellicum 42 Co Principal Investigator 42 GastroPlus TM 42 Selective Cardiac Myosin Activator 42 midstage clinical 42 oral methylnaltrexone 42 vitro dissolution 42 PCI ExTRACT TIMI 42 polyarticular 42 MOU establishes 42 RezularTM 42 Treatment Outcome 42 NPWH 42 demonstrated clinically meaningful 42 Trofex 42 ASCRS 42 Co Receptor Tropism 42 multicentre randomized controlled 42 NCCN.org 42 Oncologic Drug Advisory 42 sumbitted 42 POPRC 42 phase IIb III 42 pafuramidine maleate 42 OHRP 42 Fingolimod 42 RIO Lipids 42 Digestive Disease Week DDW 42 Kate Gelperin 42 Proposed Revisions 42 Nanavati Mehta 42 Diagnostic Criteria 42 strictest adherence 42 TransVax ™ 42 Therapeutics TCT 42 NCCLS 42 Optimata 42 requiring Asthmatx 41 peer reviewed 41 initiate Phase IIa 41 enzymatic assay 41 HemoGenix 41 Current Author Addresses 41 Hedgehog inhibitor 41 ISO TC# 41 ACM SIGCOMM 41 PK PD modeling 41 Joint Undertaking 41 Reduces Mortality 41 Phase Ib II 41 FOLFOX6 chemotherapy regimen 41 balsalazide tablet 41 Interoperability Standards 41 Peripheral Arterial 41 BESST 41 Methodological 41 meta analysis pooling 41 3 registrational trial 41 RothmanResearch.com Stock Review 41 eminent academicians 41 gene expression microarrays 41 IRSAC 41 'S EFFORTS TO 41 Sixth Plenary Session 41 biomarker assays 41 ECCO ESMO 41 ACCORD Lipid 41 Med eXpert 41 ZYBRESTAT TM 41 Nebulized Formoterol 41 Dr. Eugene Braunwald 41 evaluating Actimmune 41 Complies With 41 serologic 41 ® lenalidomide 41 st Annual Meeting 41 EMPOWER ™ 41 ASBMB 41 Viatronix V3D Colon 41 #:#-#,# CrossRef Medline [002] 41 topical calcineurin inhibitors 41 EHRA 41 predictive validity 41 placebo controlled multicenter 41 biospecimen 41 ITU Radiocommunication Sector 41 Thorough knowledge 41 Amoxicillin PULSYS Phase III 41 ECCMID 41 ACC.# 41 pharmacodynamic PD 41 NAEM 41 journal CHEST 41 pre sented 41 urodynamic 41 vidofludimus 41 selective modulator 41 Common Terminology Criteria 41 Alequel 41 microarray gene expression 41 Conformity Alliance 41 Position Statement 41 ASCLD 41 Genitourinary Cancers Symposium 41 ColorectAlert TM 41 PRECISE trial 41 OVATURE 41 Oral Presentation # 41 Hematide ™ peginesatide 41 Single Ascending Dose 41 systemic JIA 41 XSPA 41 ADRP 41 CDSCO 41 ISTODAX 41 Demonstrates Sustained 41 PANVAC VF 41 www.fasb.org 41 CTEPH 41 anticholinergic agents 41 Gøtzsche 41 immunohistochemical analysis 41 Cebs 41 non resectable 41 FASB Emerging 41 papillary thyroid carcinoma 41 Phase III AFFIRM 41 Gastrointestinal Cancers Symposium 41 Shows Promise Against 41 multivariate statistical 41 Dyax phage display 41 oral salmon calcitonin 41 evaluating mipomersen 41 CCR5 inhibitor 41 Lokpal drafting 41 GRAVITAS trial 41 Arthritis Advisory 41 QTinno TM 41 Amylin Eli Lilly 41 PKC# 41 Aortic Dissection 41 BL Mungekar 41 Extends Collaboration 41 transabdominal 41 Confirmatory 41 Technical Advisory Panel 41 rhIGF-I/rhIGFBP-3 41 Asia Pacific Telecommunity 41 Affymetrix GeneChip ® 41 Loretta M. Itri 41 NCCPA 41 EORTC NCI 41 Interagency Autism Coordinating 41 Disciplined Forces 41 Plenary Session 41 conducted retrospective cohort 41 AIDAC 41 primary aldosteronism 41 Glycopyrrolate 41 chills fever headache 41 Phase III ADT 41 European CanCer Organisation ECCO 41 toxicologic 41 DSM IV diagnoses 41 WKH 41 authority Gurian Sherman 41 Carotid Revascularization Endarterectomy vs. 41 Mantel Haenszel 41 MGMT methylation 41 delipidation 41 AAO HNS 41 ParAllele 41 Excessive Daytime Sleepiness 41 Suicidality 41 DEEP AF 41 experimentally validated 41 Heritability 41 Phase lll 41 Subtypes 40 Technical Symbology Committee 40 SF #v# 40 journal PloS Biology 40 predictive toxicology 40 Physical Therapy PTJ 40 endocrine responsive 40 PHEMCE 40 UEGW 40 Raptiva efalizumab 40 Recommends Changes 40 PRIMO CABG 40 IAQG 40 powder diffraction 40 Intervention Effectiveness 40 www.ClinicalTrials.gov 40 HPV genotyping 40 diagnosed glioblastoma 40 CDISC standards 40 Selective Electrochemical Tumor Ablation 40 AFFITOME R 40 Endocrine Society #st 40 Fraunhofer FOKUS 40 multiplex assay 40 Audit Conflicts 40 Auditing Profession 40 EASL 40 oral ghrelin agonist 40 Cerebril TM 40 PD2i ® 40 rALLy trial 40 patients coinfected 40 FDA Oncologic Drug 40 ICAAP 40 IAPC 40 ONCONASE R 40 ACR ARHP 40 fibrotic disorders 40 PD LID 40 recom mendations 40 NADiA PSA 40 small molecule tyrosine 40 AERx iDMS 40 Angiotensin Converting Enzyme 40 immunohistochemistry IHC 40 Gabriela Knaul 40 Adheres 40 oral PrEP 40 PF # [002] 40 AHA Scientific Sessions 40 Patients Treated With 40 TSXV MFS 40 leukotriene receptor antagonists 40 FDA Antiviral Drugs 40 Circulatory System Devices 40 PROactive Study 40 Investigational Drugs 40 NSABB 40 immunoblot 40 non cirrhotic portal 40 Fifth Decennial International 40 IEEE ComSoc 40 Temsirolimus 40 GeSI 40 CRMD# 40 GTCbio 3rd 40 Interdisciplinary Humanities 40 Proprietary Medicinal Products CPMP 40 Denufosol 40 Lamfalussy process 40 miRNA profiling 40 IGAP 40 Exhibitor Profiles 40 intermittent dosing 40 Biobanks 40 Solid Tumor 40 initiated Phase Ib 40 chemosensitivity 40 SACGHS 40 vitro ADME 40 analy sis 40 NSABP 40 peer reviewed manuscripts 40 androgen receptor antagonist 40 Aplidin 40 Vicor PD2i 40 Psychiatric Assn 40 Investigational Compound 40 EGTT 40 ANCS 40 Cystic Fibrosis Questionnaire Revised 40 Watson LIMS 40 NR Shetty 40 Appellate Panel 40 immunohistochemical 40 Clinical Antipsychotic Trials 40 ESMO 40 brown baggers #x# 40 CT perfusion imaging 40 Neuropsychiatric Inventory NPI 40 INTOSAI 40 circadian rhythm disorders 40 visit www.ashrae.org 40 Mass Torts 40 Francesca Bravi 40 SWOG 40 Enunciating 40 #rd Annual CTRC 40 L Romesh 40 kitchen wine cellars 40 www.pharsight.com 40 Greenhouse Gas Inventories 40 Endocrine Society Annual Meeting 40 Bosutinib 40 NCT# ClinicalTrials.gov 40 Diamyd R 40 Informal consultations 40 Functional neuroimaging 40 PRESEPT 40 Pharmacopeial Convention 40 neurocognitive dysfunction 40 basal insulin analogue 40 tularemia infections 40 toxicogenomics 40 MTIA 40 Chemophase 40 Dr JJ Irani 40 Abstract P# [001] 40 ISHLT 40 Tanespimycin 40 ACNFP 40 digitizing pathology 40 chairman Bob Horen 40 viral tropism 40 hydrophobic docetaxel prodrug nanoparticle 40 severely immunosuppressed 40 NP2 Enkephalin 40 V3D Colon 40 varenicline Chantix 40 Mr. Yves Rosconi 40 VITAL Trial 40 genotype phenotype 40 flays govt 40 BCR ABL inhibitor 40 please visit www.hnba.com 40 Senaka Bibile 40 LEAPS H#N# 40 AlloMap testing 40 DSMB recommended 40 Dataflow Manager 40 NS5A 40 orally administered inhibitor 40 Iron Deficiency Anemia 40 Secondary endpoints include 40 ® DDW 40 convenorship 40 Opportunistic Infections CROI 40 RUGs IV 40 Intraoperative Surgical Planning 40 Standardization CEN 40 cMET 40 Endometrial Regenerative Cells 40 updated NCCN Guidelines 40 related CMV Retinitis 40 NADiA 40 commented Nicholas Landekic 40 ToxCast ™ 40 Sipuleucel T 40 PIANC 40 SPARLON 40 anti arrhythmic drug 40 Paediatric Academic Societies 40 biomarker discovery validation 40 CGEMS 40 carotid artery narrowing 40 AACR EORTC NCI 40 eprodisate Fibrillex TM 40 PhenoSense 40 Licenses Novel 39 isoflavone supplement 39 IDABC 39 Stefano Conti 39 Ziprasidone 39 confirmatory pivotal 39 ESEM 39 Advanced Neuroendocrine Tumors 39 IFRS changeover 39 TMPRSS2 ERG fusion 39 IPSAS 39 TPSAC 39 CDISC SDTM 39 K DOQI 39 LEVADEX ™ 39 AIPLA 39 schizophreniform 39 asymptomatic hyperuricemia 39 Liposomal Grb 2 39 olanzapine LAI 39 Satyanand Mishra 39 ImmuKnow R 39 deforolimus 39 metabolite identification 39 causal inference 39 Ultrasound guided 39 OECS PPS 39 Phase III LibiGel 39 Sociodemographic 39 sigma receptor 39 genomic biomarkers 39 Medicsight CAD 39 Bayesian inference 39 Crohn colitis 39 acyclovir Lauriad R 39 Medicine ISMRM 39 Vascular Biology ATVB 39 adjunctively 39 BioSante LibiGel Phase III 39 ASH Annual Meeting 39 IQWiG 39 POSIDUR TM 39 JNCCN 39 Tumor Response 39 HCV polymerase 39 RoACTEMRA 39 plenary lectures 39 FLEG 39 CIMZIA R 39 Breast Brachytherapy 39 IVIVC 39 th Annual Interscience 39 CLOSED SESSION 39 Cardioxyl 39 Aeolus Pharmaceuticals Announces 39 Dr. Raafat Fahim 39 unblinding 39 Sun.Star Cebu Sunnex 39 preterm lamb 39 subcutaneous methylnaltrexone 39 CLINICAL PHARMACOLOGY 39 T SPOT.TB 39 magnetic resonance CMR 39 ;) CO 39 A/#/# [002] 39 MultiGEN 39 Kevin Hrusovsky President 39 H. Herz 39 Animal Efficacy 39 IVD CE 39 multiparametric 39 iSBTc 39 Robbert Dijkgraaf 39 rEEG 39 neo adjuvant 39 Wound Healing Society 39 SNT-MC#/idebenone 39 Cardiolite ® 39 Sweden Karolinska Institutet 39 PUBLIC AGENDA 39 Interoperability Demonstration 39 journal Gynecologic Oncology 39 antiepileptics 39 PRCAI 39 PROTECT AF 39 Breast Cancer Symposium 39 Postmarket 39 please visit www.accellera.org 39 Femara letrozole 39 dietary acrylamide 39 Surfaxin LS 39 aripiprazole Abilify 39 MGd 39 Mitochondrial dysfunction 39 Idiopathic 39 metastatic colorectal carcinoma 39 Faraone SV 39 PLAC test 39 Summarizes 39 spirometric 39 NASDAQ Listings Qualifications 39 International Papillomavirus 39 Barry Straube 39 synDNA TM 39 Ragweed Allergy 39 Dewey LeBoeuf LLP 39 nd Annual Meeting 39 vitro molecular diagnostic 39 rhITF 39 FSMB 39 aggressive systemic mastocytosis 39 ICCD COP 7 39 sporicidal product 39 Nasdaq SGEN 39 EGFR HER2 39 tumor histology 39 externally validated 39 NOPR 39 Kosan dependence 39 Reports Inducement Grants 39 secretagogue 39 EACs 39 receptor tyrosine kinase inhibitor 39 OvaDx 39 CLSI 39 ZFP Therapeutics 39 AUPD 39 KN excels 39 MBTOC 39 InterAcademy Council IAC 39 CHIME Foundation 39 Significantly Strengthens 39 Chemiluminescence 39 Clinical Data Interchange 39 interpretability 39 paroxetine sertraline 39 Erythropoiesis stimulating agents 39 includedin 39 Phase III TRIST 39 Lixivaptan 39 sorafenib Nexavar 39 GHTF 39 Illumina GoldenGate 39 rheumatoid arthritis inflammatory bowel 39 MelaFind pivotal 39 UNICRI 39 Major Depressive Disorder MDD 39 Gynecologic Investigation 39 Poster Session 39 methodologically sound 39 FINA Doping 39 Srinath Reddy 39 COPD inhalation anthrax 39 Postmenopausal hormone therapy 39 AABB accredited 39 SBRP 39 develop HBV reactivation 39 MGN# 39 gene expression assays 39 Avvo Rating 39 SpyGlass Power 39 Al Ogaili 39 CLIA waiver 39 chemometrics 39 II Clinical Trial 39 presymptomatic 39 APTIMA HPV 39 immunomagnetic separation 39 Benlysta belimumab 39 FDLI 39 Standards Consortium CDISC 39 Concomitant 39 metabolomic profiling 39 please visit www.ldra.com 38 inhaled liposomal ciprofloxacin 38 PJ Devereaux 38 convergent validity 38 Multivariate Index 38 eCTD format 38 Neupro R 38 QTinno 38 SynCon TM 38 pharmacological therapy 38 selectively inhibiting 38 Dr. Giles Peatfield 38 ESTRO 38 ICMJE 38 Cardio3KG 38 immunofluorescent 38 Pediatric Academic Society 38 Therapeutic Intervention 38 myeloproliferative diseases 38 clinically validated 38 discriminant 38 Formalize 38 Avastin adjuvant 38 NQF endorsed 38 Limperopoulos 38 #nd Annual Meeting 38 Nick Balletta 38 NGS Collection 38 WG1 38 apricitabine ATC 38 evaluating carfilzomib 38 Geodon ziprasidone 38 cathepsin K inhibitor 38 guanfacine extended release 38 Callisto initiated 38 SLEC RTL 38 infliximab etanercept 38 Spiegelmer ® 38 journal BJU International 38 Competency Standards 38 Phase 1b trial 38 5 HT2A 38 GMX# 38 Compellis 38 hematopoietic cancers 38 please visit www.teleworkexchange.com 38 Eslicarbazepine acetate 38 IVSC 38 Dickersin 38 Speaker Penpa Tsering 38 TCG TNC 38 Paul Talalay 38 prospective observational 38 CROI 38 Mermin oversees 38 inverse agonist 38 Impaired glucose tolerance 38 Monogram Trofile Assay 38 National Authorising Officer 38 histamine dihydrochloride 38 Sanger Sequencing 38 Clinical Trial Evaluating 38 interpersonal psychotherapy IPT 38 phase Ib 38 mass spectrometric 38 Afri Can creative 38 Sphingomab TM 38 oocyte cryopreservation 38 GRI G3 38 transgenic mouse models 38 Pharmacokinetic parameters 38 insulin glulisine 38 Invites Nominations 38 denileukin diftitox 38 pathological hallmarks 38 BioNumerik 38 p# MAP kinase inhibitor 38 #:# certified [002] 38 acute mania 38 NBSB 38 Cardiopulmonary bypass 38 Dr Raymond Atuguba 38 Genitourinary Cancer 38 workshops symposia 38 Association NRECA 38 Room #AB [002] 38 Hwang fabricated 38 randomized Phase 2b 38 Neurological Societies 38 DDW ® 38 Mass Spectrometry MS 38 NHAMCS 38 neuropsychologists 38 CMV vaccine 38 EORTC NCI AACR 38 Transocean thwarts 38 recurrent epithelial ovarian 38 www.nccn.org 38 American Psychiatric Assn 38 multiple linear regression 38 Annual Transcatheter Cardiovascular 38 Chemical Biology Consortium 38 NAB FASTROAD 38 occipital nerve stimulation 38 Alzhemed TM 38 visit www.ey.com 38 Reuben Granich 38 CML CP 38 IEEE P# Working 38 diagnosing ADHD 38 Evidence Therapeutic 38 biomarker validation 38 Applied Nutrition CFSAN 38 PCA Rx 38 mTOR inhibition 38 ESCRS 38 JM Mauskar 38 Fifteenth Annual 38 Vectibix panitumumab 38 Zevalin consolidation